MYLAN 421 (Methyldopa 500 mg)
Pill imprint MYLAN 421 has been identified as Methyldopa 500 mg.
Methyldopa is used in the treatment of high blood pressure; hypertensive emergency and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy. Methyldopa 500 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- MYLAN 421
- Strength:
- 500 mg
- Color:
- Orange
- Size:
- 19.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, centrally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0421
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
sodium lauryl sulfate
titanium dioxide
triacetin
FD&C Yellow No. 6
FD&C Blue No. 2
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0201 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
More about methyldopa
Consumer resources
- Other brands: Aldomet
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
